Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06565845
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-18
Brief Title:
Analysis of Various Treatment Methods of Granulomatous Lobular Mastitis
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Analysis of the Clinical Characteristics and Three Treatment Methods of Granulomatous Lobular Mastitis
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Granulomatous lobular mastitis GLM is a rare benign breast disease that is difficult to distinguish from breast cancer based on clinical and imaging findings and there is currently no standard treatment This study aims to analyze the clinical characteristics and demographic data of GLM patients and to compare the overall effectiveness of three treatment methods surgery alone triple anti-tuberculosis drug therapy alone and combined surgery with triple anti-tuberculosis drug therapy with the goal of providing new insights for clinical treatment
Detailed Description:
In recent years the incidence of this disease has been increasing annually The incidence of GLM is region-specific being higher in Mediterranean regions and Asian countries The etiology is currently unclear but many studies suggest that GLM is associated with autoimmune disorders hormonal imbalances and microbial infections GLM has a long course is difficult to treat and prone to recurrence causing significant trauma to the patients breast appearance and overall well-being Currently the main treatment methods for GLM include surgical treatment drug therapy combined surgery with drug therapy and close observation Surgical treatment options mainly include abscess incision and drainage segmental resection subcutaneous mastectomy mastectomy and breast reconstruction Although surgical treatment can rapidly improve the condition the recurrence rate reported in the literature ranges from 5 to 50 Although GLM is a benign disease it can severely impact the patients normal life causing physical and psychological trauma However few studies have included patients subjective treatment experiences in the evaluation of treatment outcomes
To date there have been no studies comparing the efficacy of three treatment methods surgery alone triple anti-tuberculosis drug therapy alone and combined surgery with triple anti-tuberculosis drug therapy in the same population of GLM patients This study aims to compare the efficacy and patient satisfaction of these three treatment methods with the hope of providing new insights for clinical treatment options
To date there have been no studies comparing the efficacy of three treatment methods surgery alone triple anti-tuberculosis drug therapy alone and combined surgery with triple anti-tuberculosis drug therapy in the same population of GLM patients This study aims to compare the efficacy and patient satisfaction of these three treatment methods with the hope of providing new insights for clinical treatment options
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None